Category Archives: TB

Thinking strategically about nutrition supports disease responses and more

By on .

The following is a guest post by Heather B. Davis, MPH, and Emily A. Bobrow, PhD, MPH, of MEASURE Evaluation Who has a strategic interest in nutrition? Is the world on course to meet global nutrition targets? What does it mean to have a robust national dialogue to support the development of practical nutrition solutions? […]

CUGH 2019: Researchers say training, resources for the “private sector,” including traditional healers, will be critical to TB control

By on .

CHICAGO – To find the missing tuberculosis cases that go unreported each year, national TB programs will have to reach out to the places where the most people seek care, researchers said here. And that’s not in public hospitals or clinics where capacities to respond to TB already exist, but in the private sector in […]

Advocates, physicians to pharmaceutical company: lower price on government-supported drug, aid research

By on .

It has been heralded as an important step in ending the threat of tuberculosis in the United States, and one with ramifications for countries with higher incidence of the disease: a new drug to treat TB infection before it causes illness, treat it more quickly than current regimens. With standard treatment consisting of daily pills […]

Budget cuts endanger the CDC’s Tuberculosis Research Program

By on .

The following is a guest post by Coco Jervis, senior U.S.and global policy associate Treatment Action Group , the science-based treatment advocacy organization. According to the World Health Organization, an estimated 8.7 million people became sick with tuberculosis in 2011, and more than 1 million are expected to die of the disease this year alone. […]

Entrepreneur uses cell phones to fight counterfeit drugs while linking patients with answers

By on .

“In healthcare we have to work with what’s already happening” Nathan Sigworth was a freshman in college when he spent a month visiting a small hospital in India, and made a simple discovery: economics there dictated a very different delivery of health care than he was used to seeing. In time, he discovered that while […]

GeneXpert analysis puts numbers, consistency on test’s advantages

By on .

McGill University researchers who analyzed 18 studies involving more than 7,000 people released findings today showing the GeneXpert rapid diagnostic test for tuberculosis detected the disease among 67 percent of samples in which it had been missed by smear microscopy, the most common diagnostic tool in low-resource but high burden countries. While both tests require […]

Programs, research, funding for tuberculosis response leave children behind

By on .

When a disease spreads among people living in close quarters and poverty, the question of how hard it is hitting some of the most vulnerable people in its path seems obvious: How many children are suffering from, and dying of tuberculosis? The answer: Nobody seems to know. Numbers are just the tip of the iceberg […]

WHO 2012 Global Tuberculosis Report shows uneven progress

By on .

New cases of TB have been falling for several years, while access to care has expanded,  and deaths from tuberculosis have dropped by forty percent since the mid-1990s.  That’s some of the progress highlighted in the World Health Organization’s Global Tuberculosis Report released last week, and it means the target of halving the death rate […]

Global Fund TB allocation shows need for work, action, groups say

By on .

When the Global Fund Board released its September meeting “decision points” document on funding allocation methods, it was, watchers noted, a part of a piece of a work in progress. But one decision will hold for the next year, and will impact efforts to roll out advances in tuberculosis diagnosis and treatment — the decision […]

Collaboration seeks to speed new TB treatments

By on .

About half a century has passed since a new tuberculosis drug was put to use, and in that time the challenges to successful treatment of the disease have only grown, with bacteria adapting faster to conditions that allowed it to flourish than science and funding for research. Morphing into forms that require from months to […]